Related Experiment Video
Updated: Aug 13, 2026

10:35
A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
Prisoner settles case for right to start methadone in prison
Summary
An inmate successfully challenged Correctional Service Canada's policy preventing prisoners from starting methadone treatment. This landmark case affirmed the right to essential opioid addiction treatment in federal prisons.
Area of Science:
- Public Health
- Criminal Justice
- Addiction Medicine
Background:
- A federal inmate challenged Correctional Service Canada's (CSC) policy prohibiting the initiation of methadone maintenance treatment (MMT) during incarceration.
- The inmate, a previous heroin user, argued that the policy was unconstitutional and violated his right to necessary medical care.
Discussion:
- The settlement highlights the legal and ethical considerations surrounding opioid agonist therapy in correctional facilities.
- It raises questions about the balance between institutional security and the healthcare needs of incarcerated individuals with substance use disorders.
Key Insights:
- The case underscores the importance of providing evidence-based addiction treatment, including MMT, within the prison system.
- Successful legal challenges can drive policy changes that improve health outcomes for inmates.
Outlook:
- This settlement may pave the way for broader access to MMT and other harm reduction services for federal inmates.
- Future legal and policy developments will likely focus on ensuring continuity of care for opioid use disorder upon release from incarceration.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...

